IP Library Assignment 032720/0243
Patent Assignment
Reel/Frame 032720/0243

Assignment of Assignor's Interest

Recorded: 2014-04-21 Pages: 6
Assignor
Assignee
MSD ITALIA S.R.L.
VIA VITORCHIANO 151, ROME, 00189, ITALY
Covered Properties (41)
Method for Producing in Vitro the Rna-Dependent Rna Polymerase and Terminal Nucleotidyl Transferase Activities Encoded by Hepatitis C Virus (Hcv)
Patent: 6,383,768 →
Application: 08/952,981 →
Use of Cntf (Ciliary Neurotrophic Factor) Receptor Activators for the Treatment of Obesity
Patent: 6,565,869 →
Application: 09/308,368 →
Variant of Ciliary Neutortophic Factor and Dna Encoding the Variant
Patent: 6,660,467 →
Application: 09/381,393 →
Synthesis of Polynucleotides Having Random Sequences
Patent: 6,350,595 →
Application: 09/530,128 →
Method for Identifying a Hcv Rna-Dependent Rna Polymerase Inhibitor
Patent: 7,399,605 →
Application: 10/085,476 →
Publication: US 2002/0164722
Method of Screening for Anti-Obesity Agents Using Ciliary Neutrophic Factor Receptor
Patent: 6,960,558 →
Application: 10/356,191 →
Publication: US 2003/0176346
Hepatitis C Virus Replicons and Replicon Enhanced Cells
Patent: 8,198,426 →
Application: 10/467,000 →
Publication: US 2004/0067486
Hepatitis C Virus Vaccine
Patent: 7,598,362 →
Application: 10/492,178 →
Publication: US 2004/0247615
Substituted Pyrimido[1,2-a]Azepines Useful as Hiv 1NTEGRASE Inhibitors
Patent: 7,414,045 →
Application: 10/540,449 →
Publication: US 2006/0046985
Chimpanzee Adenovirus Vaccine Carriers
Patent: 8,216,834 →
Application: 10/587,389 →
Publication: US 2011/0217332
Carcinoembryonic Antigen Fusions and Uses Thereof
Patent: 8,188,244 →
Application: 10/589,180 →
Publication: US 2008/0311137
Covalently Stabilized Chimeric Coiled-Coil Hiv GP41 N-Peptides with Improved Antiviral Activity.
Patent: 7,811,577 →
Application: 11/628,483 →
Publication: US 2007/0224212
Heterocycle Derivatives as Histone Deacetylase (Hdac) Inhibitors
Patent: 7,863,294 →
Application: 11/792,294 →
Publication: US 2009/0048228
Hiv Integrase Inhibitors
Patent: 7,981,879 →
Application: 11/887,305 →
Publication: US 2009/0253681
Telomerase Reverse Transcriptase Fusion Protein, Nucleotides Encoding It, and Uses Thereof
Patent: 8,017,387 →
Application: 11/974,067 →
Publication: US 2008/0090778
Thiophene and Thiazole Substituted Trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors
Patent: 7,977,374 →
Application: 11/991,576 →
Publication: US 2009/0156591
Hiv Integrase Inhibitors
Patent: 7,939,537 →
Application: 11/992,531 →
Publication: US 2009/0221571
Antiviral Indoles
Patent: 7,767,660 →
Application: 12/002,996 →
Publication: US 2008/0214522
Antiviral Indoles
Patent: 7,781,422 →
Application: 12/004,013 →
Publication: US 2008/0153895
Amide Substituted Indazoles as Poly(Adp-Ribose)Polymerase(Parp) Inhibitors
Patent: 8,071,623 →
Application: 12/006,993 →
Publication: US 2008/0167345
Tetrahydro-4H-Pyrido[1,2-A] Pyrimidines Useful as Hiv Integrase Inhibitors
Patent: 7,968,553 →
Application: 12/075,514 →
Publication: US 2008/0176869
Matrix Metalloproteinase 11 Vaccine
Patent: 8,106,176 →
Application: 12/083,031 →
Publication: US 2009/0155298
Heterocycle Substituted Amide and Sulfur Amide Derivatives as Histone Deacetylase (Hdac) Inhibitors
Patent: 8,080,573 →
Application: 12/084,269 →
Publication: US 2009/0156619
Heterocycle Substituted Ketone Derivatives as Histone Deacetylase (Hdac) Inhibitors
Patent: 8,026,265 →
Application: 12/086,812 →
Publication: US 2010/0234374
N-Substituted Hydroxypyrimidinone Carboxamide Inhibitors of Hiv Integrase
Patent: 7,820,660 →
Application: 12/214,595 →
Publication: US 2008/0275004
Therapeutic Compounds
Patent: 7,989,438 →
Application: 12/218,425 →
Publication: US 2009/0048239
A Pharmaceutical Composition Comprising Oxyntomodulin Derivatives and a Method for Reducing Body Weight Using the Composition
Patent: 7,928,058 →
Application: 12/223,942 →
Publication: US 2010/0144617
Thiophene and Thiazole Substituted Trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors
Patent: 7,799,825 →
Application: 12/223,943 →
Publication: US 2009/0076101
Pyridinone and Pyridazinone Derivatives as Inhibitors of Poly (Adp-Ribose) Polymerase (Parp)
Patent: 8,188,084 →
Application: 12/227,513 →
Publication: US 2009/0176765
Synthetic Gene Encoding Human Epidermal Growth Factor 2/Neu Antigen and Uses Thereof
Patent: 7,662,586 →
Application: 12/291,886 →
Publication: US 2009/0098604
Macrocyclic Compounds as Antiviral Agents
Patent: 8,178,520 →
Application: 12/300,887 →
Publication: US 2009/0258891
Macrocyclic Compounds as Antiviral Agents
Patent: 8,314,062 →
Application: 12/306,137 →
Publication: US 2009/0312241
Hcv NS3 Protease Inhibitors
Patent: 8,377,873 →
Application: 12/446,296 →
Publication: US 2010/0298210
HCV NS3 Protease Inhibitors
Application: 12/447,342 →
Publication: US 2010/0099695
Nucleoside Cyclic Phosphoramidates for the Treatment of Rna-Dependent Rna Viral Infection
Patent: 8,148,349 →
Application: 12/519,038 →
Publication: US 2010/0022468
Antiviral Indoles
Patent: 8,101,595 →
Application: 12/519,570 →
Publication: US 2010/0076046
Nucleoside Derivatives as Inhibitors of Viral Polymerases
Patent: 8,183,216 →
Application: 12/679,713 →
Publication: US 2010/0210581
Pyridazinone Derivatives as Parp Inhibitors
Patent: 8,268,827 →
Application: 12/739,262 →
Publication: US 2010/0261709
3,4-Substituted Pyrrolidine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Patent: 8,354,545 →
Application: 12/747,605 →
Publication: US 2010/0280009
Therapeutic Compounds
Patent: 8,591,878 →
Application: 12/919,128 →
Publication: US 2011/0002884
Matrix Metalloproteinase 11 Vaccine
Patent: 8,492,522 →
Application: 13/332,580 →
Publication: US 2012/0177679
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 29, 2012
From: PALAZZOLO, LEGAL REPRESENTATIVE OF THE ESTATE OF ELISABETTA SPORENO, DECEASED, PAOLO; COLLOCA, STEFANO; NICOSIA, ALFREDO; CIRILLO, AGOSTINO
To: ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA
Reel/Frame 028278/0021 →
Merger Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
Change of Name Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
Merger Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →